Project Grant HT94252510008
Award Date
12/1/24
Completion Date
11/30/26
Dollars Obligated
$428K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
The Defense Health Agency awarded a $1,260,839 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The grant, effective May 1, 2025 through April 30, 2029, will support research targeting EHMT1/2 to overcome therapy-resistant ovarian cancer. As a prominent public research university, the University of Colorado-Denver leverages its expertise across multiple...
The Department of Defense's Defense Health Agency awarded a $2,264,623 Project Grant to Vanderbilt University Medical Center (VUMC) on May 1, 2025 under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "TOXICANT-MEDIATED PULMONARY HYPERTENSION IN SOUTHWEST ASIA VETERANS", will support advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The research aims to investigate medical...
The U.S. Defense Health Agency has awarded a $499,998 Project Grant to the University of Colorado-Denver under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from November 1, 2024 to October 31, 2026, is for developing a preservation method for vascularized composite allotransplantation (VCA) during static cold storage. This research aims to transform healthcare for military service members and the broader public by...
This $345,800 Project Grant was awarded on May 1, 2024 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts. The grant supports research on the "Role of Stress Granules in the Pathogenesis and Therapy of Pulmonary Hypertension", with a performance period from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program funds a...
This $2,488,002.00 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a multi-year research effort by the University of Colorado-Denver to develop biomarkers for detecting acute, subacute, and chronic organ injury following neonatal congenital heart disease surgery. The research aims to improve diagnostic capabilities and treatment outcomes for this patient population. The award runs from April 1, 2024 to March 31, 2028, and...
The Department of the Army Medical Command awarded a $554,876 Project Grant to the Regents of the University of California, San Francisco to investigate the pathobiological role of dysregulated pulmonary vascular metabolism in systemic sclerosis-associated pulmonary arterial hypertension. The grant was awarded on August 1, 2022 under the Military Medical Research and Development program (CFDA 12.420) to support basic, applied, and advanced biomedical research that transforms military and...
The Defense Health Agency awarded a $320,000 Project Grant to the Regents of the University of Colorado Denver under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from August 1, 2023 to July 31, 2025 to determine the mechanisms underlying remyelination by surviving oligodendrocytes. The research aims to advance understanding of how the central nervous system repairs myelin sheaths, with potential implications for treating multiple...
The University of Arizona was awarded a $2,611,139 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to support research on Novel Therapeutics for Pulmonary Hypertension. The four-year award beginning May 1, 2022 will fund the development of new drug therapies to treat pulmonary hypertension, a condition affecting blood pressure in the lungs that can impact military service members. As part of the work,...
This Project Grant from the Defense Health Agency provides $349,939 to the University of Colorado Denver under the Military Medical Research and Development federal grant program (CFDA 12.420) from February 1, 2023 to January 31, 2026. The grant funds research on transfemoral osseointegrated prosthesis limb-load symmetry training. As the program description notes, the Military Medical Research and Development program supports basic, applied, and advanced biomedical research to improve military...
The federal Project Grant award of $1,225,783 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a fully automated deep learning-based framework for segmentation and treatment response assessment of lesions on PSMA PET/CT in prostate cancer. This research, conducted by the University of Colorado-Denver, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...